Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Deubiquitylase USP52 Promotes Bladder Cancer Progression by Modulating Ferroptosis through Stabilizing SLC7A11/xCT

11 Oct 2024

Abstract excerpt

Bladder cancer (BLCA) is a prevalent cancer with high case-fatality rates and a substantial economic burden worldwide. Understanding its molecular underpinnings to guide clinical management is crucial. Ferroptosis, a recently described non-apoptotic form of cell death, is initiated by the lethal accumulation of iron-dependent lipid peroxidation products. Despite growing interest, the roles and vulnerabilities...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Epigenetics and DNA Methylation
Share to Ferroptosis and cancer prognosis
Share to RNA modifications and cancer

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 39392373
DOI: 10.1002/advs.202403995

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 20 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Deubiquitylase USP52 Promotes Bladder Cancer Progression by Modulating Ferroptosis through Stabilizing SLC7A11/xCTPMID 39392373Read ↗

ALOX5 deficiency contributes to bladder cancer progression by mediating ferroptosis escapeSemantic proximity Read ↗

The Deubiquitinase USP2 Inhibits Clear Cell Renal Cell Carcinoma by Activating the p53 Signaling Pathway and Inducing FerroptosisSemantic proximity Read ↗

Ferroptosis: A new therapeutic target for bladder cancerSemantic proximity Read ↗

Identification of mRNA vaccines and conserved ferroptosis related immune landscape for individual precision treatment in bladder cancerSemantic proximity Read ↗

DARS2 Promotes Bladder Cancer Progression by Enhancing PINK1-Mediated MitophagySemantic proximity Read ↗

Ferroptosis Patterns and Tumor Microenvironment Infiltration Characterization in Bladder CancerSemantic proximity Read ↗

Disulfidptosis and ferroptosis related genes define the immune microenvironment and NUBPL serves as a potential biomarker for predicting prognosis and immunotherapy response in bladder cancerSemantic proximity Read ↗

The deubiquitinase USP24 suppresses ferroptosis in triple-negative breast cancer by stabilizing DHODH proteinSemantic proximity Read ↗

USP10 Inhibits Ferroptosis via Deubiquinating POLR2A in Head and Neck Squamous Cell CarcinomaSemantic proximity Read ↗

ATR‐dependent ubiquitin‐specific protease 20 phosphorylation confers oxaliplatin and ferroptosis resistanceSemantic proximity Read ↗

Targeting LAMP2 synergizes with gemcitabine to inhibit bladder cancer progression via modulating STING degradation and regulating macrophage phenotypes.Semantic proximity Read ↗

UBE2T silencing suppresses proliferation and induces cell cycle arrest and apoptosis in bladder cancer cellsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.